Unknown PHASE4 INTERVENTIONAL 2-arm NCT03333408

Determining the Necessity for Postoperative Antibiotics After Salivary Stent Placement

Sponsor: Louisiana State University Health Sciences Center in New Orleans

Interventions Postoperative Oral Antibiotics (Clindamycin or Augmentin)

Updated 11 times since 2017 Last updated: Oct 31, 2023 Started: Jun 15, 2018 Primary completion: Dec 31, 2024 Completion: Dec 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Salivary Duct and is currently ongoing. Louisiana State University Health Sciences Center in New Orleans leads this study, which shows 11 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Dec 2025 — Present [monthly]

Unknown PHASE4

Status: Recruiting → Unknown
Sep 2024 — Dec 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Dec 2023 — Jul 2024 [monthly]

Recruiting PHASE4
May 2022 — Dec 2023 [monthly]

Recruiting PHASE4

▶ Show 6 earlier versions

Mar 2021 — May 2022 [monthly]

Recruiting PHASE4
Jan 2021 — Mar 2021 [monthly]

Recruiting PHASE4
Apr 2019 — Jan 2021 [monthly]

Recruiting PHASE4
Aug 2018 — Apr 2019 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Aug 2018 [monthly]

Not Yet Recruiting PHASE4
Dec 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Louisiana State University Health Sciences Center in New Orleans
Our Lady of the Lake Hospital

Data source: Our Lady of the Lake Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baton Rouge, United States